Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I've been on the fence about joining Edwards, and this post definitely adds some food for thought. The MedTech sector is notoriously volatile, and hearing about internal shifts like delayed timelines and team restructuring, even if explained away, is concerning. I'd be keen to hear if this is a widespread feeling or isolated incidents. Trying to get a clear picture before making any career decisions.
Echoing the sentiment here. It's subtle, but there's a definite shift in atmosphere. Conversations feel more guarded, and there's an undercurrent of uncertainty that wasn't present even six months ago. While I understand the need for strategic adjustments, the lack of transparency around project changes is a bit unsettling. Hoping it's just a temporary phase and not a sign of larger issues brewing.